Yury Isaevich Grinshtein

Prof. Dr. Yury Isaevich Grinshtein

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SSSvetlana Shalnova
Svetlana Shalnova
VMVictoria A Metelskaya
Victoria A Metelskaya
VKVladimir Kutsenko
Vladimir Kutsenko
Elena YarovayaElena Yarovaya
Elena Yarovaya
AKA. V. Kapustina
A. V. Kapustina
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To perform a population analysis of Non-High Density Lipoprotein Cholesterol level (non-HDL-c) in Russian population and to evaluate its association with cardiovascular events.Material and Methods. The material consisted of results obtained from 11 regions of the ESSE-RF1 Study and from 4 regions of the ESSE-RF2 Study. Study protocols were identical. The studies were performed in 2012-2014 and 2017, respectively. Endpoints were assessed in 19041 people aged 35-64 years. The median follow-up was 6.5 years in ESSE RF (1) and 3.8 years in ESSE RF(2). Analysis was performed for three lipid variables: total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and non-HDLC in two samples: the general population sample and the same sample without individuals with coronary heart disease (CHD), myocardial infarction (MI) and/or stroke history and not taking statins (the population sample of "without a history of cardiovascular diseases [CVD]". The analysis of nonlinear associations was performed using the generalized additive Cox model. The combined cardiovascular endpoint was represented by cardiovascular death and nonfatal MI and stroke. Traditional and laboratory FRs, socio-demographic parameters were analyzed. The significance level for all tested hypotheses was set to be 0.05.Results. The prevalence of elevated non-HDL-C level (>3.7 mmol/l) was found to be 74.6%. No gender differences were found: there was 74.6% for men and 74.5% for women. Both mean values and prevalence of elevated non-HDL-C were increased with age in women, and its level was slightly decreased in men after 55 years old. Almost all analyzed RFs were significantly associated with elevated non-HDL-C in these two population samples. In both samples elevated total CH and elevated LDL-C were associated with all-cause mortality after correction for all RFs. On the contrary, the non-HDL-C was associated with CVD combined end pints. It has been shown that the risk of these end points increases uniformly with increase in levels of non HDL cholesterol, no nonlinear associations were found.Conclusion. The results of a population-based analysis of non-HDL-C performed in the Russian population for the first time confirmed that elevated non-HDL-C levels contribute significantly to determining the risk of cardiovascular events in the medium term. It can be assumed that the new risk scales (SCORE2 and SCORE OP) proposed by the European Society of Cardiology and the European Society of Preventive Cardiology, which include non-HDL C instead of TC, will allow adequate assessment of 10-year cardiovascular risk for Russians. However, continued monitoring of endpoints in order to obtain stable associations is required.

11 August 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YBYulia Balanova
Yulia Balanova
SSSvetlana Shalnova
Svetlana Shalnova
AIAsiia (Asiya) Imaeva
Asiia (Asiya) Imaeva
VKVladimir Kutsenko
Vladimir Kutsenko
AKA. V. Kapustina
A. V. Kapustina
ЮГЮ. И. Гринштейн
Ю. И. Гринштейн
Aim. To study the contribution of obesity, including abdominal obesity (AO), to the risk of all-cause death and cardiovascular events (CVE) in the Russian population.Material and methods. The representative samples of the Russian population aged 25-64 years from the ESSE-RF (2012-2014) and ESSE-RF2 (2017) studies were analyzed (n=22869). A modular questionnaire and standard epidemiological methods for assessing risk factors were used. The body mass index (BMI) was calculated using the following equation: BMI=body mass (kg)/height (m2). Overweight was defined as 25,0≤ BMI ≤29,9 kg/m2, while obesity — as BMI ≥30,0 kg/m2, and AO — as waist circumference ≥102 cm in men and ≥88 cm in women. High blood pressure (BP) was defined as systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg. The presence of diabetes with type indication was assessed by a questionnaire. In this analysis, carbohydrate metabolism disorders were defined as fasting glucose ≥6,1 mmol/l and/or a history of diabetes. The prospective observational cohort was formed from 14 regions included in ESSE-RF and ESSE-RF2. Every 2 years, the following were assessed: causes of death, non-fatal CVD, new cases of cardiovascular diseases and cardiovascular events. Statistical analysis was performed using the statistical programming language and the R environment (version 4.1) with open source code. To assess survival, Kaplan-Meier survival curves were used with the log-rank test with Holm's adjustment. Associations with endpoints were assessed using Cox models. The differences for all tested hypotheses were considered significant at p<0,05.Results. The presence of obesity, including AO, significantly worsens survival in the Russian cohort (p<0,001), and is also significantly associated with fatal and non-fatal CVD (p<0,001). The significance of obesity is preserved in multivariate analysis adjusted for sex, age and region of residence. The lowest all-cause death risk is shifted towards overweight. The risk of fatal and non-fatal cardiovascular diseases increases with increasing BMI. In the Russian cohort, the combination of obesity with carbohydrate metabolism disorders and elevated blood pressure significantly worsens the prognosis (p<0,001) compared to each condition separately.Conclusion. Obesity, including AO, is associated with worsening survival in the Russian population. Despite the obesity paradox, in which the lowest all-cause death risk is shifted towards overweight, the risk of CVD increases with increasing BMI in the Russian cohort. To control obesity, it is important to improve the detection of obesity, including through medical check-ups and preventive examinations, as well as the choice of treatment tactics for obese patients according to clinical guidelines.

26 May 2017 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MCMaria A. Cherkashina
Maria A. Cherkashina
YGYury Isaevich Grinshtein
Yury Isaevich Grinshtein
MPMarina Petrova
Marina Petrova
VSV. V. Shabalin
V. V. Shabalin
RRR. R. Ruf
R. R. Ruf
To estimate the prevalence, awareness, treatment and control of arterial hypertension among adult inhabitants of Krasnoyarsk Krai using the data from Russian multicenter epidemiological study ESSE-RF (Epidemiological Survey of cardiovascular diSEases in different regions of the Russian Federation). The study included 1603 subjects 25 to 64 years old selected by means of systemic multistage stratified randomization among urban and rural inhabitants of Krasnoyarsk Krai recruited between February 2014 and June 2014. Office blood pressure (BP) was measured twice with “Omron” automated BP device on the right arm in the sitting position in presence of medical personnel. Arterial hypertension (HTN) was defined as systolic BP of at least 140 mmHg and/or diastolic BP of at least 90 mmHg or self-reported previous elevated BP registration or use of antihypertensive treatment. Treatment efficacy was defined as percentage of patients achieved the target BP level among those who received antihypertensive medications, and HTN control as percentage of people achieved the target BP level among all hypertensives. The gender distribution was 652 males (39.4%) and 951 females (60.6%). The average level of systolic BP was 133.4 ± 0.5 mmHg, diastolic BP – 82.9 ± 0.3 mmHg. The average prevalence of HTN was estimated at 49.4% and appeared to be higher than similar parameter based on the data of 10 regions from the ESSE-RF study (44%). The average prevalence of HTN was estimated at 56.3% in males and 43.7% in females. The HTN prevalence in rural community was significantly higher in comparison with urban community (63.4 ± 2.4 vs. 44.2 ± 1.5%, p < 0.01). The average rate of HTN awareness in Krasnoyarsk Krai was 77.9% (average Russian value from ESSE-RF study was 73.1%). The average use of antihypertensive treatment, its efficacy and HTN control in Krasnoyarsk Krai were estimated at 59.5%, 31.6% and 18.8%, respectively. Estimated prevalence of HTN in Krasnoyarsk Krai is higher than the average Russian parameter. The average HTN prevalence among men is higher than in women. The rural inhabitants are more likely to have hypertension compared with urban inhabitants. Despite high levels of HTN awareness and antihypertensive medication intake, the antihypertensive treatment efficacy in Krasnoyarsk Krai appeared to be lower in comparison with average Russian ESSE-RF values.

27 July 2023 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
VSV.V. Shabalin
V.V. Shabalin
YGYury Isaevich Grinshtein
Yury Isaevich Grinshtein
RRR.R. Ruf
R.R. Ruf
NSN.S. Samsonov
N.S. Samsonov
A brief review addresses the problem of asymptomatic hyperuricemia, its association with cardiometabolic and renal manifestations, controversial and unresolved issues on its interpretation and drug therapy. The discrepancies in the proposed approaches to managing this disorder by various expert communities are highlighted. A more restrained and balanced strategy is discussed when deciding on the inclusion of urate-lowering therapy.

1 August 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YGYury Isaevich Grinshtein
Yury Isaevich Grinshtein
ASAndrei Savchenko
Andrei Savchenko
AKAleksandra Kosinova
Aleksandra Kosinova
MGMaxim Goncharov
Maxim Goncharov
Sensitivity to acetylsalicylic acid (ASA) is important in the treatment of patients with coronary heart disease (CHD) after coronary artery bypass grafting (CABG). Patients were divided into ASA sensitive (sASA) and ASA resistant (rASA) by the activity of platelet aggregation induced arachidonic acid (ARA) together with ASA. Induced platelet aggregation activity was studied in sASA and rASA patients with CHD before and after CABG. The level of synthesis of primary and secondary reactive oxygen species (ROS) by platelets was determined using chemiluminescent analysis. The activity of NAD- and NADP-dependent dehydrogenases in platelets was determined by the bioluminescent method. It was found that the aggregation activity of platelets depended on the sensitivity of CHD patients to ASA and decreased during postoperative ASA therapy. The most pronounced differences in metabolic parameters of platelets in sASA and rASA patients were detected by Nox2 activity. The synthesis of secondary ROS by platelets of CHD patients did not depend on the sensitivity of patients to ASA but increased during postoperative treatment with ASA. The activity of NAD(P)-dependent dehydrogenases in platelets did not differ in sASA and rASA patients with CHD.

1 January 2017 in Russian Journal of Preventive Medicine
Verified
Journal Article
Open access
PDF file
YBYulia Balanova
Yulia Balanova
AIAsiia (Asiya) Imaeva
Asiia (Asiya) Imaeva
SYSergey S. Yakushin
Sergey S. Yakushin
EFE. V. Filippov
E. V. Filippov
OBO. A. Belova
O. A. Belova
SSSvetlana Shalnova
Svetlana Shalnova
Medical article медицинская статья